
Over deze podcast
BioCentury's streaming commentary on biotech industry trends, plus interviews with KOLs. For three decades, BioCentury has helped biopharma executives and investors make business-critical decisions and build larger networks with peers across the innovation ecosystem.
396 afleveringen · Levenswetenschappen
BioCentury This Week
Nieuwste afleveringEp. 392 - Biotech markets: Pause before the storm?
Over deze podcast
BioCentury's streaming commentary on biotech industry trends, plus interviews with KOLs. For three decades, BioCentury has helped biopharma executives and investors make business-critical decisions and build larger networks with peers across the innovation ecosystem.
Recente afleveringen
- Ep. 391 - China deals, Beam lawsuit, MFN models, Nobel winners6 okt · 30 min
- Ep. 390 - Live from Amsterdam: Grand Rounds Europe takeaways30 sep · 34 min
- Ep. 389 - IgA nephropathy, Overton hearing, reverse mergers' new look29 sep · 37 min
- Ep. 388 - Biotech IPOs, CAR T safety & pharma tariffs22 sep · 32 min
- Ep. 387 - Psychedelics at FDA, Mike Davis’ CDER & tRNAs15 sep · 31 min
- Ep. 386 - Novartis misses, pharma deals analysis, MFN carve-outs9 sep · 35 min
- Ep. 385 - MFN deals, Lilly takeout, FDA pick Overton1 sep · 36 min
- Ep. 384 - Back to School Special: The global FIH trials race28 aug · 43 min
- Ep. 383 - Moderna, Genentech obesity deal, Trump's FDA pick25 aug · 19 min
- Ep. 382 - Summer’s venture wave; drugging beta-catenin; Capricor & FDA18 aug · 25 min